GMXAY News and Press, Genmab A/S S/Adr From 04/28/18

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. U.S. Treasury Secretary Steven Mnuchin is scheduled to lead a delegation to China f...

The following slide deck was published by Genmab A/S in conjunction with this Read more ...

Genmab A/S webcast presentation now available for on-demand viewing: dbVIC - Deutsche Bank ADR Virtual Investor Conference Canada NewsWire COPENHAGEN, Denmark, March 26, 2018 Company invites individual and institutional investors, as well as advisors, to log-on to view...

NEW YORK , March 21, 2018 /PRNewswire/ -- Deutsche Bank today announced the addition of presenters for its Depositary Receipts Virtual Investor Conference ("dbVIC") on March 22 nd , featuring live webcast presentations from international companies with American Depositary Receipt (...

Genmab A/S to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on March 22, 2018 Canada NewsWire COPENHAGEN, Denmark, March 21, 2018 Company invites individual and institutional investors, as well as advisors, to attend interactive, real-time virtual ev...

Company Announcement  Copenhagen, Denmark; February 21, 2018 – Genmab A/S (Nasdaq Copenhagen: GEN) announced today its Annual Report for 2017.  Below is a summary of business progress and financial performance for the year, and financial outlook for ...

Company Announcement  Net sales of DARZALEX in 2017 totaled USD 1,242 million Genmab receives royalties on worldwide sales from Janssen Biotech, Inc.   Copenhagen, Denmark; January 23, 2018 – Genmab A/S (Nasdaq Copenhagen: GEN) an...

Company Announcement  Novartis intends to transition the commercial availability of Arzerra to limited availability via compassionate use programs for treatment of CLL in non-US markets. Novartis will continue to market for CLL in the US Novartis will work with r...

Company Announcement U.S. FDA grants Priority Review to daratumumab in combination with bortezomib, melphalan and prednisone for the treatment of patients with newly diagnosed multiple myeloma ineligible for autologous stem cell transplant May 21, 2018 PDUFA date ...

Company Announcement Major shareholder announcement for Genmab A/S Copenhagen, Denmark; January 9, 2018 – Genmab A/S (Nasdaq Copenhagen: GEN) announces under reference to Section 29 of the Danish Securities Trading Act that Artisan Partners Limited Partn...